Markets:

Overview

News

Currencies

International

Treasuries

Merit Medical Systems, Inc. - Common Stock (NQ:MMSI)

88.36 +0.97 (+1.11%)

Streaming Delayed Price Updated: 10:28 AM EST, Dec 29, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Merit Medical Systems, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Analyst Ratings for Merit Medical Systems ↗

April 17, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2022 ↗

December 20, 2022

Via Benzinga

Lantheus Holdings Stock Showing Market Leadership; Earns 94 RS Rating ↗

November 29, 2022

Lantheus Holdings stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 90 to 94.

Via Investor's Business Daily

Earnings Scheduled For October 28, 2021 ↗

October 28, 2021

Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million. •...

Via Benzinga

Earnings Scheduled For February 22, 2023 ↗

February 22, 2023

Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

December 01, 2022

During Thursday's session, 108 stocks hit new 52-week highs.

Via Benzinga

Merit Medical Systems: Q3 Earnings Insights ↗

October 26, 2022

Merit Medical Systems (NASDAQ:MMSI) reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

A Preview Of Merit Medical Systems's Earnings ↗

October 25, 2022

Merit Medical Systems (NASDAQ:MMSI) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Recap: Merit Medical Systems Q2 Earnings ↗

July 27, 2022

Merit Medical Systems (NASDAQ:MMSI) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Merit Medical Bullish On FY23 Operating Margin Of 18-21%, Needham Says Could Exceed ↗

April 18, 2022

At the Annual Needham Healthcare Conference, Merit Medical Systems Inc's (NASDAQ: MMSI) management said that inflationary pressures and supply chain issues have been manageable and have not had a...

Via Benzinga

Merger Arbitrage Mondays - Google (GOOG) Acquires Cybersecurity Firm Mandiant (MNDT) ↗

March 14, 2022

Merger activity declined last week with three new deals announced and five deals completed. Two of the three new deals announced were potential deals in the works. I was surprised...

Via Benzinga

Medical Device Maker Merit Medical Mulls Sale: Reuters ↗

March 10, 2022

Merit Medical Systems Inc (NASDAQ: MMSI) is exploring options that include an outright sale to a private equity firm, Reuters reported citing people familiar with the...

Via Benzinga

Recap: Merit Medical Systems Q4 Earnings ↗

February 24, 2022

Merit Medical Systems (NASDAQ:MMSI) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:05 PM. Here's what investors need to know about the announcement....

Via Benzinga

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗

February 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...

Via Benzinga

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

Merit Medical Systems Inc (MMSI) Q3 2021 Earnings Call Transcript ↗

October 28, 2021

MMSI earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug ↗

October 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In...

Via Benzinga

Merit Medical Systems Inc (MMSI) Q2 2021 Earnings Call Transcript ↗

July 30, 2021

MMSI earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

NYSE:MMSI Shareholder Notice: Update in Lawsuit Against Merit Medical Systems, Inc. ↗

July 07, 2021

San Diego, CA -- (SBWIRE) -- 07/07/2021 -- The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in shares of Merit Medical Systems, Inc. (NYSE:MMSI).

Via SBWire

Topics Lawsuit

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗

October 24, 2021

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...

Via Benzinga

Merit Medical Systems Inc (MMSI) Q1 2021 Earnings Call Transcript ↗

April 30, 2021

MMSI earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

NYSE:MMSI Investor Notice: Update in Lawsuit Against Merit Medical Systems, Inc. (NYSE:MMSI) ↗

April 30, 2021

San Diego, CA -- (SBWIRE) -- 04/30/2021 -- An investor in Merit Medical Systems, Inc. (NYSE:MMSI) shares filed a lawsuit in December 2019, against Merit Medical Systems, Inc. over alleged violations of...

Via SBWire

Topics Lawsuit

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself ↗

September 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...

Via Benzinga

Merit Medical Systems: Q1 Earnings Insights ↗

April 29, 2021

Shares of Merit Medical Systems (NASDAQ:MMSI) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 36.84% year...

Via Benzinga

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab ↗

September 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...

Via Benzinga

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical ↗

August 31, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

Stocks That Hit 52-Week Highs On Friday ↗

July 30, 2021

On Friday morning, 154 companies achieved new highs for the year. Significant Points: The largest company by market cap to break to a new 52-week high was Nike (...

Via Benzinga

The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs ↗

July 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs ↗

July 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs ↗

April 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.